Agency Information Collection Activities; Announcement of Office of Management and Budget; Extension of Expiration Date for MedWatch (Food and Drug Administration Medical Products Reporting Program) Form, 62593-62594 [E6-17907]

Download as PDF 62593 Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices Trans No. Acquiring Acquired Entities 20061845 ..... Tenaska Power Fund, L.P ....................... William J. Haugland ................................. 20061848 ..... 20061857 ..... Corel Holdings, L.P .................................. Wind Point Partners VI, L.P ..................... InterVideo, Inc .......................................... Spire Capital Partners, L.P ...................... 20061858 ..... Citizens Communications Company ........ 20061863 20061870 20061872 20070003 Edmund N. Ansin ..................................... Illinois Tool Works, Inc ............................. Canadian Natural Resources, Limited ..... Hospitality Properties Trust ...................... Commonwealth Telephone Enterprises, Inc. Tribune Company .................................... Click Commerce, Inc ................................ Anadarko Petroleum Corporation ............ Oak Hill Capital Partners, L.P .................. Bemis, LLC., Halpin Line Construction, LLC., Hawkeye Group, LLC. Premier Utility Locating, LLC. InterVideo, Inc. Highline Data, LLC., The National Underwriter Company. Commonwealth Telephone Enterprises, Inc. WLVI, Inc. Click Commerce, Inc. Anadarko Canada Corporation. TravelCenters of America, Inc. ..... ..... ..... ..... Transactions Granted Early Termination—10/11/2006 20061810 20061849 20061869 20061871 ..... ..... ..... ..... AT&T, Inc ................................................. John C. Hampton Revocable Trust ......... Issac E. Larian and Angela Larian .......... BB&T Corporation .................................... Interpath Communications, Inc ................ West Fraser Timber Co., Ltd ................... Newell Rubbermaid Inc ............................ Mellon Financial Corporation ................... Interpath Communications, Inc. Babine Forest Products, Limited. The Little Tikes Company, Inc. AFCO Credit Corporation. Transactions Granted Early Termination—10/13/2006 20061803 ..... Medical Action Industries, Inc .................. FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative, or Renee Hallman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H– 303, Washington, DC 20580, (202) 326– 3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 06–8901 Filed 10–25–06; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary [Document Identifier: OS–0990–000] ycherry on PROD1PC64 with NOTICES 30-Day Notice; Agency Information Collection Activities: Proposed Collection; Comment Request Agency: Office of the Secretary. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, VerDate Aug<31>2005 15:21 Oct 25, 2006 Jkt 211001 Medegen Holdings, LLC .......................... utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Type of Information Collection Request: Regular, New Collection. Title of Information Collection: The Effect of Reducing Falls on Acute and Long-Term Care Expenses. Form/OMB No.: OS–0990–New. Attention: ASPE is planning to conduct a demonstration and evaluation of a multi-factorial fall prevention program to measure its impact on health outcomes for the elderly as well as acute and long-term care use and cost. This will be accomplished by obtaining a sample of individuals with private longterm care insurance who are age 75 and over. Frequency: One Time On Occasion. Affected Public: Individual or Households. Annual Number of Respondents: 9720. Total Annual Responses: 9,600. Average Burden Per Response: 3.54 min. Total Annual Hours: 4305. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, e-mail your request, including your address, phone number, OMB number, and OS document identifier, to Sherette.funncoleman@hhs.gov, or call the Reports Clearance Office on (202) 690–6162. Written comments and recommendations for the proposed information collections must be PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Medegen Newco, LLC. received within 30 days of this notice directly to the Desk Officer at the address below: OMB Desk Officer: John Kraemer, OMB Human Resources and Housing Branch, Attention: (OMB #0990–New), New Executive Office Building, Room 10235, Washington, DC 20503. Dated: October 23, 2006. Alice Bettencourt, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. E6–17943 Filed 10–25–06; 8:45 am] BILLING CODE 4151–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2004N–0535] Agency Information Collection Activities; Announcement of Office of Management and Budget; Extension of Expiration Date for MedWatch (Food and Drug Administration Medical Products Reporting Program) Form AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of expiration date. SUMMARY: The Food and Drug Administration (FDA) is announcing that, under the Paperwork Reduction Act of 1995 (the PRA), the Office of Management and Budget (OMB) has extended the expiration date to May 1, 2007, for the use of the prior version of Form FDA 3500A for ‘‘MedWatch: Food and Drug Administration Medical E:\FR\FM\26OCN1.SGM 26OCN1 62594 Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices unless it displays a currently valid OMB control number. FOR FURTHER INFORMATION CONTACT: ycherry on PROD1PC64 with NOTICES Products Reporting Program’’ (the MedWatch Program). Dated: October 19, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6–17907 Filed 10–25–06; 8:45 am] Elizabeth Berbakos, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827– 1482. SUPPLEMENTARY INFORMATION: In the Federal Register of August 16, 2005 (70 FR 48157), FDA announced that a proposed collection of information entitled ‘‘MedWatch: Food and Drug Administration Medical Products Reporting Program’’ had been submitted to OMB for approval under the PRA. The collection of information included the use of two forms used in the MedWatch Program—Form FDA 3500 and Form FDA 3500A. In that notice, we responded to public comments pertaining to proposed revisions to Form FDA 3500 and Form FDA 3500A. Several comments from industry stated that considerable resources would be required to modify computer systems and processes to begin using the mandatory reporting form—Form FDA 3500A. In response to these comments, we stated: ‘‘[T]o allow mandatory reporters time to make the necessary changes to their computer systems and processes to conform to the revised Form FDA 3500A, FDA is granting a grace period of 1 year. During this transition period FDA will accept both the newly effective Form FDA 3500A and the prior version of the form.’’ In the Federal Register of December 7, 2005 (70 FR 72843), FDA announced that OMB had approved the information collection for the MedWatch Program as submitted to OMB on August 16, 2005. In that notice, we stated: ‘‘As requested by the agency, in addition to the approval of the revised forms, the existing forms are approved for continued use for the next 12 months to allow for the industry to make necessary changes to their computerized systems.’’ In response to several recent requests from industry that we grant more time to make necessary changes to computerized systems, we requested and OMB has agreed to extend approval to use the prior version of Form FDA 3500A until May 1, 2007. The expiration date for the newly revised Form FDA 3500A remains unchanged— October 31, 2008. The prior version of Form FDA 3500A is available for downloading at https://www.fda.gov/ medwatch/getforms.htm, and the expiration date on the form has been revised to May 1, 2007. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information VerDate Aug<31>2005 15:21 Oct 25, 2006 Jkt 211001 BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Dental Products Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Dental Products Panel of the Medical Devices Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on November 9, 2006, from 8 a.m. to 5 p.m. Location: Holiday Inn, Walker/ Whetstone Rooms, Two Montgomery Village Ave., Gaithersburg, MD. Contact Person: Michael J. Ryan, Center for Devices and Radiological Health (HFZ–480), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301–827–5283, ext. 175, e-mail at: michael.ryan@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 3014512518. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will discuss, make recommendations, and vote on a premarket approval application for a collagen material, which contains a bone morphogenetic protein, for oral maxillofacial bone grafting procedures. Background information, including the agenda and questions for the committee, will be available to the public 1 business day before the meeting on the Internet at https://www.fda.gov/cdrh/ panel (click on Upcoming CDRH Advisory Panel/Committee Meetings). Procedure: On November 9, 2006, from 8:30 a.m. to 5 p.m., the meeting will be open to the public. Interested PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before November 2, 2006. Oral presentations from the public will be scheduled for approximately 30 minutes at the beginning of committee deliberations and for approximately 30 minutes near the end of the deliberations. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before November 2, 2006. Closed Committee Deliberations: On November 9, 2006, from 8 a.m. to 8:30 a.m., the meeting will be closed to the public to permit FDA to present to the committee trade secret and/or confidential commercial information regarding pending and future agency issues (5 U.S.C. 552b(c)(4)) for the next year. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact AnnMarie Williams, Conference Management Staff, 301–827–7291, at least 7 days in advance of the meeting. FDA regrets that it was unable to publish this notice 15 days prior to the Dental Products Panel of the Medical Devices Advisory Committee meeting. Because the agency believes there is some urgency to bring these issues to public discussion and qualified members of the Dental Products Panel of the Medical Devices Advisory Committee were available at this time, the Commissioner of Food and Drugs concluded that it was in the public interest to hold this meeting even if there was not sufficient time for the customary 15-day public notice. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 71, Number 207 (Thursday, October 26, 2006)]
[Notices]
[Pages 62593-62594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17907]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N-0535]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget; Extension of Expiration Date for MedWatch 
(Food and Drug Administration Medical Products Reporting Program) Form

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of expiration date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that, 
under the Paperwork Reduction Act of 1995 (the PRA), the Office of 
Management and Budget (OMB) has extended the expiration date to May 1, 
2007, for the use of the prior version of Form FDA 3500A for 
``MedWatch: Food and Drug Administration Medical

[[Page 62594]]

Products Reporting Program'' (the MedWatch Program).

FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of 
Management Programs (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-1482.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 16, 2005 
(70 FR 48157), FDA announced that a proposed collection of information 
entitled ``MedWatch: Food and Drug Administration Medical Products 
Reporting Program'' had been submitted to OMB for approval under the 
PRA. The collection of information included the use of two forms used 
in the MedWatch Program--Form FDA 3500 and Form FDA 3500A. In that 
notice, we responded to public comments pertaining to proposed 
revisions to Form FDA 3500 and Form FDA 3500A. Several comments from 
industry stated that considerable resources would be required to modify 
computer systems and processes to begin using the mandatory reporting 
form--Form FDA 3500A. In response to these comments, we stated: ``[T]o 
allow mandatory reporters time to make the necessary changes to their 
computer systems and processes to conform to the revised Form FDA 
3500A, FDA is granting a grace period of 1 year. During this transition 
period FDA will accept both the newly effective Form FDA 3500A and the 
prior version of the form.''
    In the Federal Register of December 7, 2005 (70 FR 72843), FDA 
announced that OMB had approved the information collection for the 
MedWatch Program as submitted to OMB on August 16, 2005. In that 
notice, we stated: ``As requested by the agency, in addition to the 
approval of the revised forms, the existing forms are approved for 
continued use for the next 12 months to allow for the industry to make 
necessary changes to their computerized systems.'' In response to 
several recent requests from industry that we grant more time to make 
necessary changes to computerized systems, we requested and OMB has 
agreed to extend approval to use the prior version of Form FDA 3500A 
until May 1, 2007. The expiration date for the newly revised Form FDA 
3500A remains unchanged--October 31, 2008. The prior version of Form 
FDA 3500A is available for downloading at https://www.fda.gov/medwatch/
getforms.htm, and the expiration date on the form has been revised to 
May 1, 2007.
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless it displays a 
currently valid OMB control number.

    Dated: October 19, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-17907 Filed 10-25-06; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.